Clinical applications of proteomics: Proteomic pattern diagnostics

Journal of Mammary Gland Biology and Neoplasia

Volumn 7, Issue 4, 2002, Pages 433-440

  Petricoin, Emanuel F ^a   Paweletz, Cloud P ^b   Liotta, Lance A ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Genetic algorithms; Mass spectrometry; Nipple fluid; Patterns diagnostics; Proteomics

Indexed keywords

BIOLOGICAL MARKER; BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEOME; TUMOR MARKER;

ATAXIA TELANGIECTASIA; BODY FLUID; BREAST CANCER; EARLY DIAGNOSIS; GENETIC ALGORITHM; GERM LINE; HUMAN; MAMMOGRAPHY; MASS SPECTROMETRY; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS; ALGORITHM; BREAST; BREAST TUMOR; METABOLISM; METHODOLOGY; NIPPLE; TIME;

ALGORITHMS; BODY FLUIDS; BREAST; BREAST NEOPLASMS; HUMANS; MASS SPECTROMETRY; NIPPLES; PROTEOME; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0141782299     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024042200521     Document Type: Review

References (42)

1. E. F. Petricoin, K. C. Zoon, E. C. Kohn, J. C. Barrett, and L. A. Liotta (2002). Clinical proteomics: Translating benchside promise into bedside reality. Nat. Rev. Drug Disc. 1:683-695.
2. L. A. Liotta and E. C. Kohn (May 17, 2001). The microenvironment of the tumour-host interface. Nature 411(6835):375-379.
3. B. L. Adam, A. Vlahou, O. J. Semmes, and G. L. Wright, Jr. (Oct. 2001). Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1(10):1264-1270.
4. D. Carter, J. F. Douglass, C. D. Cornellison, M. W. Retter, J. C. Johnson, A. A. Bennington, T. P. Fleming, S. G. Reed, R. L. Houghton, D. L. Diamond, and T. S. Vedvick (May 28, 2002). Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 41(21):6714-6722.
5. C. Rosty, L. Christa, S. Kuzdzal, W. M. Baldwin, M. L. Zahurak, F. Carnot, D. W. Chan, M. Canto, K. D. Lillemoe, J. L. Cameron, C. J. Yeo, R. H. Hruban, and M. Goggins (Mar 15, 2002). Identification of hepatocarcinoma- intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 62(6):1868-1875.
6. Z. Xiao, B. L. Adam, L. H. Cazares, M. A. Davis, J. W. Clements, P. F. Schellhammer, E. A. Dalmasso, and G. L. Wright, Jr. (Aug 15, 2001). Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res, 61(16):6029-6033.
7. J. H. Kim, S. J. Skates, T. Uede, K. K. Wong, J. O. Schorge, C. M. Feltmate, R. S. Berkowitz, D. W. Cramer, and S. C. Mok (Apr 3, 2002). Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 287(13):1671-1679.
8. J. R. Harris, M. E. Lippman, U. Veronesi, W. Willett (1992). Breast cancer. N. Engl. J. Med. 327:319-328.
9. J. G. Elmore, M. B. Barton, V. M. Moceri, S. Polk, P. J. Arena, and S. W. Fletcher (1998). Ten-year risk of false positive screening mammograms and clinical breast examinations. N. Engl. J. Med. 338:1089-1096.
10. B. Fisher (1992). The evolution of paradigms for the management of breast cancer: A personal perspective. Cancer Res. 52:2371-2383.
11. M. Swift (1994). Ionizing radiation, breast cancer, and ataxia telangiectasia. J. Natl. Cancer. Inst. 86:1571-1572.
12. S. K. Sharan, M. Morimatsu, U. Albrecht, et al. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386:804-810.
13. E. Evron, W. C. Dooley, C. B. Umbricht, D. Rosenthal, N. Sacchi, E. Gabrielson, A. B. Soito, D.T. Hung, B. M. Ljung, N. E. Davidson, and S. Sukumar (2001). Detection of breast cancer in ductal lavage fluid by methylation-specific PCR. Lancet 337:1336-1337.
14. M. Wrensch, N. L. Petrakis, et al. (1993) Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy. Am. J. Epidemiol. 137:829-833.
15. E. R. Sauter, E. Ross, M. Daley, et al. (1997) Nipple aspirate fluid: A promising noninvasive method to identify cellular markers of breast cancer risk. Br. J. Cancer 76:494-501.
16. Y. Liu, J. L. Wang, H. Chang, S. H. Barsky, and M. Nguyen (2000). Breast-cancer diagnosis with nipple fluid bFGF. Lancet 356:567.
17. Y. Zhao, J. V. Sigitas, N. Klar, N. L. Sadowsky, C. M. Kaelin, and B. Smith (2001). Nipple fluid carcinoembryonic antigen and prostate antigen in cancer bearing and tumor-free breasts. J. Clin. Oncol. 19:1462-1467.
18. E. R. Sauter, M. Daly, K. Linahan, H. Ehya, P. F. Engstrem, G. Bonney, E. A. Ross, H. Yu, and E. Diamandis. (1996). Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 5:967-970.
19. E. B. King, K. L. Chew, N. L. Petrakis, and V. L. Ernster (1983). Nipple apirate cytology for the study of breast cancer precursor. J. Natl. Cancer Inst. 71:1115-1121.
20. L. Foretova, J. Garber, N. Sadowsky, S. Verselis, D. Joseph, A. Andrade, P. Gudrais, D. Fairclough, and F. Li. (1998). Carcinoembryonic antigen in breast nipple spirate fluid. Cancer Epidemiol. Biomarkers Prev. 7:195-198.
21. B. L. Adam, A. Vlahou, O. J. Semmes, and G. L. Wright Jr. (October 2001). Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics. 1(10):1264-1270.
22. H. J. Issaq, T. D. Veenstra, T. P. Conrads, and D. Felschow (2002). The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292:587-592.
23. L. H. Cazares, B. Adom, M. Word, S. Nasim, P. Schellhommer, O. Semmes, and G. Wright, Jr. (August, 2002). Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectroscopy. Clin. Cancer Res. 8(8):2541-2552.
24. G. L. Wright, L. H. Cazares, S. M. Leung, S. Nasim, B. L. Adam, T. T. Yip, P. F. Schellhammer, L. Gong, and A. Vlahou (1999). Proteinchip((R)) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 2:264-276.
25. C. P. Paweletz, J. W. Gillispie, D. K. Ornstein, N. L. Simone, M. R. Brown, K. A. Cole, Q. H. Wang, J. Huang, N. Hu, T. Yip, W. E. Rich, E. C. Kohn, L. W. Marston, T. Weber, P. Taylor, M. R. Emmert-Buck, L. A. Liotta, and E. F. Petricoin III (2000). Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Dev. Res. 49:34-42.
26. C. P. Paweletz, B. Trock, M. Pennanen, T. Tsangaris, L. A. Liotta, and E. F. Petricoin III (2001). Protein patterns of nipple aspirate fluids obtained by SELDI-TOF aid in the diagnosis of breast cancer. Dis. Markers. 17(4):301-307.
27. E. F. Petricoin, A. M. Ardekani, B. A. Hitt, P. J. Levine, V. A. Fusaro, S. M. Steinberg, G. B. Mills, C. Simone, D. A. Fishman, Kohn E. C. and L. A. Liotta (February 16, 2002). Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359(9306):572-577.
28. E. F. Petricoin III, G. B. Mills, E. S. Kohn, and L. Liotta (2002). Proteomic patterns in serum and identification of ovarian cancer. Lancet 360:170-171.
29. G. Ball, S. Mian, F. Holding, R. O. Allibone, J. Lowe, S. Ali, G. Li, S. McCardle, I. O. Ellis, C. Creaser, and R. C. Rees (March, 2002). An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics. 18(3):395-404.
30. J. Li, Z. Zhang, J. Rosenzweig, Y. Y. Wang, and D. W. Chan (August, 2002). Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48(8):1296-1304.
31. B.-L. Adam, Y. Qu, J. W. Davis, M. D. Ward, M. A. Clements, L. H. Cazares, O. Semmes, P. Schellhammer, Y. Yasvi, Z. Feng, and G. Wright, Jr. (2002). Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62:3609-3614.
32. E. F. Petricoin III, D. K. Ornstein, C. P. Paweletz, A. Ardekani, P. S. Hackett, B. A. Hitt, A. Velassco, C. Trucco, L. Wiegand, K. Wood, C. B. Simone, P. J. Levine, W. M. Linehan, M. R. Emmert-Buck, S. M. Steinberg, E. C. Kohn, and L. A. Liotta (October 16, 2002). Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 94(20):1576-1578.
33. Y. Qu, B. L. Adam, Y. Yasui, M. D. Ward, L. H. Cazares, P. F. Schellhammer, Z. Feng, O. J. Semmes, and G. L. Wright Jr (October, 2002). Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 48(10):1835-1843.
34. A. A. Alizadeh, M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, J. I. Powell, L. Yang, G. E. Marti, T. Moore, J. Hudson, L. Lu, D. B. Lewis, R. Tibshirani, G. Sherlock, W. C. Chan, T. C. Greiner, D. D. Weisenburger, J. O. Armitage, R. Warnke, R. Levy, W. Wilson, M. R. Grever, J. C. Byrd, D. Botstein, P. O. Brown, and L. M. Staudt (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
35. T. R. Golub, D. K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J. P. Mesirov, H. Coller, M. L. Loh, J. R. Downing, M. A. Caligiuri, C. D. Bloomfield, and E. S. Lander (1999). Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286:531-537.
36. D. Lindahl, J. Palmer, and L. Edenbrandt (1999). Myocardial SPET: Artificial neural networks describe extent and severity of perfusion defects. Clin. Physiol. 19:497-503.
37. P. Lapuerta, G. J. L'Italien, S. Paul, R. C. Hendel, J. A. Leppo, and L. A. Fleisher (1998). Nerual network assessment of perioperative cardiac risk in vascular surgery patients. Med. Decis. Making 18:70-75.
38. J. H. Holland, (ed.) (1994). Adaptation in natural and artificial systems: An introductory analysis with applications to biology, control, and artificial intelligence, 3rd edn. MIT Press, Cambridge, MA.
39. T. Kohonen (1990). The self-organizing map. Proc. IEEE 78:1464-1480.
40. Kohonen. T. (1982). Self-organizing formation of topologically correct feature maps. Biol. Cybern. 43(1):59-69.
41. J. T. Tou and R. Gonzalez (eds.). Pattern classification by distance functions. In Pattern Recognition Principles. Addison Wesley, Reading, MA, pp. 75-109.
42. For full press release please go to: http://www.correlogic.com/ questlabcorp_final.htm